- Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms
-
Saad F, Doros G, Haider KS, Haider A
- KMID: 2424295
- Investig Clin Urol.
- 2018 Nov;59(6):399-409.
- doi: 10.4111/icu.2018.59.6.399
PURPOSE: To analyze data from an observational, prospective, cumulative registry study in 805 hypogonadal men stratified by mild or moderate-to-severe lower urinary tract symptoms (LUTS) according to International Prostate Symptom... -
- CITED
-
- Close
- SHARE
-
- Close
- Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men
-
Saad F, Yassin A, Haider A, Doros G, Gooren L
- KMID: 2155307
- Korean J Urol.
- 2015 Apr;56(4):310-317.
- doi: 10.4111/kju.2015.56.4.310
PURPOSE: To investigate the potential benefits of testosterone administration to elderly men (>65 years) with late-onset hypogonadism (LOH) in comparison with younger men and to assess the safety of testosterone... -
- CITED
-
- Close
- SHARE
-
- Close
